Brief: Taisho Pharmaceutical Holdings: To Buy UPSA For $1.6 Billion From Bristol-Myers
Dec 19 (Reuters) - Japan's Taisho Pharmaceutical Holdings Co
Ltd 4581.T :
* TO BUY UPSA FOR $1.6 BILLION FROM BRISTOL-MYERS
Source text for Eikon: urn:newsml:reuters.com:*:nTSXS6df63
Further company coverage: 4581.T
(Reporting By Chris Gallagher)
((chris.gallagher@thomsonreuters.com;))
Recent news on Taisho Pharmaceutical Holdings Co
See all newsBrief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Squeeze Out Price If Taisho Disagrees With Their Demand - Nikkei
Brief: Curi RMB Capital, Kaname Capital To Request Tokyo Court To Revise Taisho Pharmaceutical's Tender Offer Price If Taisho Disagrees Their Demand - Nikkei
Activist fund Oasis says it may take legal action over Taisho's management buyout
Brief: Curi RMB Capital Opposes Taisho Pharmaceutical HD's Management Buyout
To Retire Treasury Shares Worth 3.65% Of Outstanding Stock On April 10